Brazil says China's Sinopharm seeks COVID-19 vaccine emergency-use authorization

SAO PAULO - China National Pharmaceutical Group Co Ltd (Sinopharm) has applied for emergency use authorization for its COVID-19 vaccine in Brazil, the Brazilian health agency Anvisa said in a statement on Monday.

Brazil already uses another Chinese COVID-19 vaccine, Sinovac Biotech's Coronavac, which is the vaccine most administered in the South American nation. Sinopharm's vaccine is made from an inactivated virus, Anvisa said, and is recommended for people over age 18.